Related Experiment Video
Updated: Jul 4, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
[Colorectal cancer in the elderly].
1Service d'hépato-gastro-entérologie et oncologie digestive, CHU Ambroise-Paré, 9, avenue Charles-de-Gaulle, 92100 Boulogne, France. emmanuel.mitry@apr.aphp.fr
Bulletin Du Cancer
|December 17, 2008
Summary
Elderly patients over 75 with colorectal cancer are often undertreated. Optimal management requires individualized, geriatric-assessed treatment plans, with surgery considered when feasible for curative intent.
Area of Science:
- Geriatric Oncology
- Colorectal Cancer Management
- Clinical Geriatrics
Context:
- Colorectal cancer (CRC) significantly impacts individuals aged 75 and older, representing 50% of cases.
- Elderly patients with CRC frequently receive suboptimal treatment.
- Current management often falls short of optimal care standards for this demographic.
Purpose:
- To highlight the under-treatment of colorectal cancer in patients over 75.
- To emphasize the need for individualized treatment strategies in elderly CRC patients.
- To advocate for comprehensive geriatric assessment in CRC management.
Summary:
- While CRC treatment principles are similar across age groups, physiological age, comorbidities, and patient preferences are crucial for patients over 75.
- Treatment decisions must be individualized and informed by a complete geriatric evaluation.
- Multidisciplinary team meetings involving oncologists and geriatricians are essential for optimal care planning.
- Surgery is the only curative option and should be considered when medically feasible.
Impact:
- Improved treatment strategies for elderly colorectal cancer patients.
- Enhanced quality of life and outcomes for geriatric oncology patients.
- Increased consideration of surgical options in fit elderly patients with colorectal cancer.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...